What to do next for an adult male with low free testosterone and normal total testosterone levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Low Free Testosterone with Normal Total Testosterone

For an adult male with low free testosterone (5.7 pg/mL) and normal total testosterone (468 ng/dL), further evaluation is needed to determine the cause of this discrepancy, followed by appropriate treatment if symptomatic hypogonadism is confirmed.

Diagnostic Evaluation

1. Confirm Laboratory Values

  • Repeat morning total and free testosterone measurements to confirm the initial findings 1
  • Ensure free testosterone is measured by a reliable method (equilibrium dialysis is preferred) 2, 3
  • Normal total testosterone range for adult men is typically 300-800 ng/dL 1
  • Normal free testosterone range is approximately 6.6-18.1 pg/mL (as per lab reference)

2. Evaluate for Causes of Discrepancy

  • Measure sex hormone-binding globulin (SHBG) levels 1, 2
    • High SHBG is the most common cause of normal total testosterone with low free testosterone
    • Calculate free testosterone index (total testosterone/SHBG ratio) 2
  • Measure serum luteinizing hormone (LH) levels 1
    • Helps distinguish primary (testicular) from secondary (pituitary-hypothalamic) hypogonadism
  • Consider measuring estradiol levels if breast symptoms or gynecomastia are present 1

3. Assess for Common Causes of Elevated SHBG

  • Advanced age (most common cause) 4, 5
  • Liver disease
  • Hyperthyroidism
  • HIV infection
  • Medications (anticonvulsants, estrogens)

Treatment Approach

If Symptomatic Hypogonadism is Confirmed:

  1. Consider testosterone replacement therapy if the patient has:

    • Confirmed low free testosterone levels
    • Clinical symptoms of hypogonadism (decreased libido, erectile dysfunction, fatigue, decreased muscle mass, etc.)
    • No contraindications 6, 7
  2. Contraindications to testosterone therapy include:

    • Breast or prostate cancer
    • Elevated PSA (>4 ng/mL or >3 ng/mL in high-risk men)
    • Hematocrit >50%
    • Severe untreated obstructive sleep apnea
    • Severe lower urinary tract symptoms
    • Uncontrolled heart failure
    • Desire for fertility 2, 7
  3. Formulation options:

    • Transdermal preparations (gel, patch) provide more stable levels 2
    • Injectable testosterone (enanthate, cypionate)
    • Target mid-normal range testosterone levels (500-600 ng/dL) 2

If Asymptomatic:

  • Consider lifestyle modifications to improve testosterone levels:
    • Weight loss if overweight/obese 2
    • Regular physical exercise 2
    • Improved sleep hygiene
    • Stress reduction
    • Smoking cessation and alcohol reduction 2

Monitoring

  • Check testosterone levels 2-3 months after initiating treatment 2
  • Monitor for adverse effects:
    • Hematocrit and hemoglobin (polycythemia)
    • PSA and prostate symptoms
    • Cardiovascular parameters
    • Breast symptoms
    • Sleep apnea symptoms

Special Considerations

  • Age is a significant factor - patients over 60 years have a 26.3% prevalence of normal total/low free testosterone 4
  • Obesity increases aromatization of testosterone to estradiol, which can suppress LH secretion 1
  • SHBG increases with age, which can mask hypogonadism when only total testosterone is measured 4, 5
  • Relying solely on total testosterone can miss approximately 17% of hypogonadal men 4

Pitfalls to Avoid

  • Don't rely solely on total testosterone to exclude hypogonadism, especially in men over 60 4
  • Don't use unreliable free testosterone assays (analog methods have limited reliability) 3
  • Don't initiate testosterone therapy without confirming low testosterone levels on at least two separate measurements 7
  • Don't overlook the importance of SHBG in testosterone bioavailability assessment 2
  • Don't miss secondary causes of hypogonadism that may require specific treatment (pituitary tumors, etc.) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hormonal Regulation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Testosterone and ill-health in aging men.

Nature clinical practice. Endocrinology & metabolism, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.